Video Experimental Relacionado

Updated: May 5, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K

Terapia láser: ¿cuidados paliativos para el síndrome de Arlequín?

Felipe Otávio Saraiva França1, Guilherme Albuquerque Nicolau1, Mariana Machado Lima2

  • 1Department of Medicine, Centro Universitário Cesumar, Maringá, PR, Brazil.

Einstein (Sao Paulo, Brazil)
|February 19, 2026
PubMed
Resumen

La terapia láser muestra resultados prometedores para el tratamiento del síndrome de Arlequín, una afección rara que causa anomalías en la sudoración facial y rubor. Este estudio de caso indica que el tratamiento con láser mejoró los síntomas y la satisfacción del paciente.

Palabras clave:
terapia lásersíndrome de Arlequíncuidados paliativosestudio de casoanhidrosisruborsatisfacción del paciente

Más Videos Relacionados

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma09:10

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

Published on: November 15, 2024

1.1K
Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

1.1K

Videos de Conceptos Relacionados

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K